Nordea Investment Management
TEVA icon

Nordea Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Nordea Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.63M Buy
124,860
+4,071
+3% +$131K ﹤0.01% 655
2025
Q4 		$3.77M Sell
120,789
-4,082
-3% -$101K ﹤0.01% 648
2025
Q3 		$2.43M Buy
124,871
+21,969
+21% +$386K ﹤0.01% 709
2025
Q2 		$1.74M Sell
102,902
-43,767
-30% -$706K ﹤0.01% 748
2025
Q1 		$2.21M Buy
146,669
+50,313
+52% +$899K ﹤0.01% 681
2024
Q4 		$2.14M Hold
96,356
– – ﹤0.01% 679
2024
Q3 		$1.71M Buy
96,356
+4,519
+5% +$79.1K ﹤0.01% 722
2024
Q2 		$1.5M Hold
91,837
– – ﹤0.01% 743
2024
Q1 		$1.3M Buy
91,837
+2,701
+3% +$34K ﹤0.01% 779
2023
Q4 		$931K Buy
89,136
+1,521
+2% +$14.2K ﹤0.01% 838
2023
Q3 		$902K Sell
87,615
-130,573
-60% -$1.22M ﹤0.01% 828
2023
Q2 		$1.66M Sell
218,188
-20,146
-8% -$163K ﹤0.01% 730
2023
Q1 		$2.11M Buy
238,334
+3,858
+2% +$38.1K ﹤0.01% 668
2022
Q4 		$2.16M Buy
234,476
+162,970
+228% +$1.42M ﹤0.01% 659
2022
Q3 		$570K Sell
71,506
-10,019
-12% -$88.6K ﹤0.01% 874
2022
Q2 		$620K Buy
81,525
+16,106
+25% +$140K ﹤0.01% 871
2022
Q1 		$608K Hold
65,419
– – ﹤0.01% 875
2021
Q4 		$533K Buy
65,419
+5,106
+8% +$46.1K ﹤0.01% 909
2021
Q3 		$597K Hold
60,313
– – ﹤0.01% 893
2021
Q2 		$597K Hold
60,313
– – ﹤0.01% 891
2021
Q1 		$687K Sell
60,313
-51,737
-46% -$593K ﹤0.01% 848
2020
Q4 		$1.08M Hold
112,050
– – ﹤0.01% 748
2020
Q3 		$1.02M Sell
112,050
-96,174
-46% -$1.02M ﹤0.01% 722
2020
Q2 		$2.51M Buy
208,224
+108,715
+109% +$1.23M ﹤0.01% 692
2020
Q1 		$898K Hold
99,509
– – ﹤0.01% 722
2019
Q4 		$990K Hold
99,509
– – ﹤0.01% 750
2019
Q3 		$676K Hold
99,509
– – ﹤0.01% 800
2019
Q2 		$919K Sell
99,509
-2,361
-2% -$28.5K ﹤0.01% 774
2019
Q1 		$1.6M Buy
101,870
+2,172
+2% +$38.3K ﹤0.01% 902
2018
Q4 		$1.54M Buy
99,698
+189
+0.2% +$3.88K ﹤0.01% 887
2018
Q3 		$2.14M Buy
+99,509
New +$2.31M ﹤0.01% 874
2018
Q2 		– Sell
-72,824
Closed -$1.25M – 1074
2018
Q1 		$1.25M Hold
72,824
– – ﹤0.01% 814
2017
Q4 		$1.38M Sell
72,824
-102,553
-58% -$1.54M ﹤0.01% 757
2017
Q3 		$3.09M Sell
175,377
-12,709,433
-99% -$286M 0.01% 502
2017
Q2 		$428M Buy
12,884,810
+311,894
+2% +$9.65M 1.08% 28
2017
Q1 		$403M Sell
12,572,916
-687,495
-5% -$23.5M 1.07% 27
2016
Q4 		$481M Buy
13,260,411
+231,069
+2% +$9.23M 1.27% 22
2016
Q3 		$599M Buy
13,029,342
+309,593
+2% +$16.2M 1.55% 14
2016
Q2 		$639M Buy
12,719,749
+1,543,748
+14% +$82.2M 1.79% 13
2016
Q1 		$598M Buy
11,176,001
+5,745,869
+106% +$337M 1.8% 12
2015
Q4 		$356M Buy
5,430,132
+1,745,928
+47% +$108M 1.21% 23
2015
Q3 		$208M Sell
3,684,204
-870,735
-19% -$56.5M 0.77% 34
2015
Q2 		$269M Buy
4,554,939
+65,085
+1% +$4.01M 0.94% 29
2015
Q1 		$280M Buy
4,489,854
+250,691
+6% +$14.6M 1% 30
2014
Q4 		$244M Buy
4,239,163
+1,402,014
+49% +$78.1M 0.9% 33
2014
Q3 		$152M Buy
2,837,149
+1,023,299
+56% +$54.2M 0.61% 49
2014
Q2 		$95.1M Buy
1,813,850
+98,614
+6% +$5.04M 0.4% 71
2014
Q1 		$90.6M Sell
1,715,236
-1,755,986
-51% -$81.2M 0.42% 58
2013
Q4 		$139M Sell
3,471,222
-1,246,216
-26% -$49.1M 0.69% 45
2013
Q3 		$178M Buy
4,717,438
+429,670
+10% +$16.8M 0.99% 25
2013
Q2 		$168M Buy
+4,287,768
New +$167M 1.04% 24

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management's TEVA Position: Q1 2026 in Review

Nordea Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 3.4% in Q1 2026, buying an estimated $131K and bringing the position to 124,860 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Nordea Investment Management first reported a position in TEVA in Q2 2013 and has held it in 51 quarters since. The position peaked at $639M in Q2 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Nordea Investment Management held 124,860 shares of Teva Pharmaceuticals worth $3.63M as of Q1 2026.
  • Nordea Investment Management bought 4,071 Teva Pharmaceuticals shares in Q1 2026, an estimated $131K.
  • Teva Pharmaceuticals made up ﹤0.01% of Nordea Investment Management's portfolio in Q1 2026, its #655 holding.
  • Nordea Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Nordea Investment Management's Teva Pharmaceuticals position peaked at $639M in Q2 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.